Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Lannett Co Inc

+ Add to Watchlist

LN5:GR

50.041 EUR 0.067 0.13%

As of 06:57:22 ET on 05/29/2015.

Snapshot for Lannett Co Inc (LN5)

Open: 50.040 Day's Range: 49.758 - 50.041 Volume: 0
Previous Close: 50.108 52wk Range: 24.860 - 68.460 1-Yr Rtn: +71.23%

Stock Chart for LN5

No chart data available.
  • LN5:GR 49.758
  • 1M
  • 1Y
50.108
Interactive LN5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LN5

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 13.8094
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) 3.9770
Est. PEG Ratio 0.7891
Market Cap (M EUR) 1,813.62
Shares Outstanding (M) 36.24
30 Day Average Volume 178
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LN5

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LN5

Lannett Company, Inc. manufactures and distributes pharmaceutical products under its own trade name and under generic names. The Company also distributes competitive pharmaceutical products manufactured by other companies. The principal products include antifungals, antacids, dermatological preparations, and analgesic sedatives.

Michael J BogdaPresidentArthur P BedrosianChief Executive Officer
William F SchreckChief Operating OfficerMartin P GalvanVP:Finance/CFO/Treasurer
More Company Profile & Key Executives for LN5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil